Patents by Inventor Doris Marko

Doris Marko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8524307
    Abstract: The present invention relates to a method for producing a coffee blend and the coffee blend obtained by this method, wherein the coffee blend is characterized in that a coffee drink brewed from said coffee blend contains high amounts of chlorogenic acids (CGA) and N-methylpyridinium cations (NMP) and optionally, low amounts of carboxylic acid-5-hydroxytryptamides (C5-HT), has a superior antioxidative activity.
    Type: Grant
    Filed: April 27, 2011
    Date of Patent: September 3, 2013
    Assignee: TCHIBO GmbH
    Inventors: Gerhard Bytof, Ingo Lantz, Herbert Stiebitz, Doris Marko, Ute Böttler, Veronika Somoza, Christine Kotyczka, Malte Rubach, Gerhard Eisenbrand, Tamara Bakuradze, Thomas Hofmann, Roman Lang, Anika Wahl, Rudolf Eggers
  • Publication number: 20130156928
    Abstract: The present invention relates to a method for producing a coffee blend and the coffee blend obtained by this method, wherein the coffee blend is characterized in that a coffee drink brewed from said coffee blend contains high amounts of chlorogenic acids (CGA) and N-methylpyridinium cations (NMP) and optionally, low amounts of carboxylic acid-5-hydrox-ytryptamides (C5-HT), has a superior antioxidative activity.
    Type: Application
    Filed: April 27, 2011
    Publication date: June 20, 2013
    Applicant: TCHIBO GMBH
    Inventors: Gerhard Bytof, Ingo Lantz, Herbert Stiebitz, Doris Marko, Ute Böttler, Veronika Somoza, Christine Kotyczka, Malte Rubach, Gerhard Eisenbrand, Tamara Bakuradze, Thomas Hofmann, Roman Lang, Anika Wahl, Rudolf Eggers
  • Patent number: 6987092
    Abstract: The present invention relates to novel indigoid binsindole derivatives which can be used for the manufacture of a medicament for the treatment of solid cancers.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: January 17, 2006
    Assignee: Faustus Forschungs Cie. Translational Cancer Research GmbH
    Inventors: Gerhard Eisenbrand, Doris Marko, Andrea Thommet, Stefan Schwahn
  • Patent number: 6664285
    Abstract: The present invention relates to the use of cell membrane penetrating indigoid bisindole derivatives for the manufacture of a medicament for the treatment of human solid cancers.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: December 16, 2003
    Inventors: Gerhard Eisenbrand, Heinz Herbert Fiebig, Doris Marko, Ralf Hössel, Weici Tang